Citiscreen-A Combination of Precision Medicine and Artificial Intelligence in Cancer Screening
Volume 5 - Issue 2
BM Petrikovsky*
- NYU School of Medicine, USA
Received: November 30, 2021 Published: December 10, 2021
Corresponding author: NYU School of Medicine, USA
DOI: 10.32474/OAJOM.2021.05.000207
Fulltext
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Precision medicine is a novel trend for treatment and prevention that emphasizes individual variability in genes, family history, and lifestyle for each person. This approach allows doctors to accurately predict which treatment and prevention strategies will work for an individual. It is in contrast to the one-size-fits-all approach used now where treatment and prevention are designed for the average person, not taking into account the differences between individuals. Although the term “precision medicine” is new, the concept has been known for years. For example, a person requiring blood transfusion is not given blood from a random donor; instead, the donor’s blood type is matched to the recipient. Precision medicine is different from boutique medicine. The latter is designed for wealthy consumers who are not interested to wait in line, have access to a health care provider during office hours only, use generic drugs, etc. Boutique or concierge medicine are for customers who do not rely on insurance only and look for alternative ways to maintain their health and wellness.
Introduction|
CitiScreen steps of cancer screening|
Preliminary Results of Citiscreen|
References|